AMGEN INC (AMGN) Forecast, Price Target & Analyst Ratings
NASDAQ:AMGN • US0311621009
375.43 USD
-1.54 (-0.41%)
At close: Mar 10, 2026
375.43 USD
0 (0%)
After Hours: 3/10/2026, 8:05:59 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMGEN INC (AMGN).
Forecast Snapshot
Consensus Price Target
$360.25
-4.04% Downside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$4.89
Revenue Estimate8.814B
ChartMill Buy Consensus
70.95%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$360.25
Upside
-4.04%
From current price of $375.43 to mean target of $360.25, Based on 42 analyst forecasts
Low
$202.00
Median
$360.06
High
$453.60
Price Target Revisions
1 Month
5.39%
3 Months
8.16%
Price Target Summary
42 Wall Street analysts provided a forecast for the next 12 months for AMGN. The average price target is 360.25 USD. This implies a price decrease of -4.04% is expected in the next year compared to the current price of 375.43.
The average price target has been revised upward by 8.16% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
70.95%
AMGN was analyzed by 42 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about AMGN.
In the previous month the buy percentage consensus was at a similar level.
AMGN was analyzed by 42 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-10 | Jefferies | Initiate | Hold |
| 2026-02-20 | Barclays | Initiate | Equal-Weight |
| 2026-02-19 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-06 | Guggenheim | Maintains | Neutral -> Neutral |
| 2026-02-06 | Argus Research | Maintains | Buy -> Buy |
| 2026-02-04 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2026-02-04 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2026-02-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-26 | UBS | Maintains | Buy -> Buy |
| 2026-01-20 | Bernstein | Downgrade | Outperform -> Market Perform |
| 2026-01-08 | Truist Securities | Maintains | Hold -> Hold |
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-11-14 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-26 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-08-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-06 | Citigroup | Maintains | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$4.89
Revenue Estimate8.814B
Revenue Q2Q8.16%
EPS Q2Q-0.12%
Number of Analysts26
Next Earnings Revisions
Revenue (1 Month)
0.09%
Revenue (3 Months)
-0.11%
EPS (1 Month)
-5.61%
EPS (3 Months)
-5.15%
Next Earnings Summary
AMGN is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 4.89 USD and the consensus revenue estimate is 8.81B USD.
The next earnings revenue estimate has been revised downward by 0.11% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.19B 7.09% | 33.424B 18.57% | 36.751B 9.95% | 38.582B 4.98% | 39.541B 2.49% | 40.347B 2.04% | 42.067B 4.26% | 43.321B 2.98% | 44.356B 2.39% | 45.205B 1.91% | 45.395B 0.42% | |
| EBITDA YoY % growth | 12.235B -9.70% | 15.25B 24.64% | N/A 41.63% | 21.404B -0.90% | 21.63B 1.06% | 21.49B -0.65% | 23.607B 9.85% | 24.463B 3.63% | 24.886B 1.73% | 24.979B 0.37% | 25.563B 2.34% | |
| EBIT YoY % growth | 8.164B -19.43% | 9.658B 18.30% | 16.189B 67.62% | 17.027B 5.18% | 17.292B 1.56% | 17.603B 1.80% | 18.44B 4.75% | 19.799B 7.37% | 20.401B 3.04% | 21.204B 3.94% | 21.524B 1.51% | |
| Operating Margin | 28.96% | 28.90% | 44.05% | 44.13% | 43.73% | 43.63% | 43.83% | 45.70% | 45.99% | 46.91% | 47.41% | |
| EPS YoY % growth | 18.65 5.43% | 19.82 6.27% | 21.85 10.24% | 22.82 4.46% | 23.73 3.95% | 24.62 3.77% | 25.74 4.56% | 27.74 7.76% | 28.97 4.42% | 30.46 5.16% | 31.88 4.67% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.89 -0.12% | 5.86 -2.60% | 5.78 2.51% | 5.53 4.59% | 5.78 18.17% | 6.20 5.77% | 5.88 1.62% | 5.19 -6.17% |
| Revenue Q2Q % growth | 8.814B 8.16% | 9.631B 4.92% | 9.632B 0.78% | 9.818B -0.49% | 9.125B 3.53% | 9.643B 0.12% | 9.831B 2.07% | 9.946B 1.30% |
| EBITDA Q2Q % growth | 4.863B 30.45% | 5.849B 2.20% | 5.385B -26.22% | 5.39B 9.78% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.758B 60.53% | 4.334B 44.71% | 4.065B 24.54% | 4.207B 6.13% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
4.06%
EPS Next 5 Year
4.89%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.87%
Revenue Next 5 Year
3.17%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
9.80%
EBIT Next 5 Year
8.55%
AMGEN INC / AMGN Forecast FAQ
What do analysts expect the price target to be for AMGEN INC (AMGN)?
42 analysts have analysed AMGN and the average price target is 360.25 USD. This implies a price decrease of -4.04% is expected in the next year compared to the current price of 375.43.
When does AMGEN INC (AMGN) report earnings?
AMGEN INC (AMGN) will report earnings on 2026-04-29, after the market close.
What are the consensus estimates for AMGN stock next earnings?
The consensus EPS estimate for the next earnings of AMGEN INC (AMGN) is 4.89 USD and the consensus revenue estimate is 8.81B USD.
What is the expected long term growth rate for AMGN stock?
The expected long term growth rate for AMGEN INC (AMGN) is 2.87%.